Repurposed Emoxypine (Nash Pharmaceuticals)

N/A

Report date: 2025/08/19 14:09:57

Base Information

Drug NameRepurposed Emoxypine (Nash Pharmaceuticals)
Drug Alias NameNP-178
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor erythroid 2-related factor 2 modulators
TargetsNuclear factor erythroid 2-related factor 2
Therapy Area/IndicationsCrohn DiseaseInflammatory Bowel DiseasesColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNash Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesNash Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsCrohn DiseaseColitis, Ulcerative

Other Information

ATC CodeN/A
Related LinksN/A